Ruanne Barnabas , MBChB, DPhil
Email: rbarnaba@uw.edu
Phone: 206 520-3813
Dr. Barnabas is an Infectious Disease Physician-Scientist at the University of Washington and affiliate at the Fred Hutchinson Cancer Research Center. Her research focuses on HIV treatment and prevention, specifically on interventions that reduce HIV viral load and, consequently, disease progression and transmission. Her projects use both empiric data and mathematical models to better understand HIV clinical progression and transmission, and estimate the potential impact of HIV interventions at population level. The ultimate aim of her work is to estimate the effectiveness and cost-effectiveness of HIV treatment and prevention interventions to inform clinical trial design.
Kemi Doll , MD, MCSR
Email: kdoll@uw.edu
Phone: 206-543-3669
Kemi M. Doll, M.D., M.C.S.R. is a Gynecologic Oncologist in the UW Department of Obstetrics and Gynecology. She specializes in the surgical and medical treatment of uterine, ovarian, cervical and vulvar cancers. Dr. Doll's clinical interests include surgery, chemotherapy, and hormonal therapy for gynecologic cancers; and minimally invasive and robotic surgery.
Holly Harris , MPH, ScD
Email: hharris@fredhutch.org
Phone: (206) 667-2712
Dr. Harris is broadly interested in the impact of lifestyle, nutrition, and genetic factors on women’s health. Specifically, she has focused on ovarian and breast cancer, as well as on hormonally related conditions that have shared reproductive risk factors with these diseases, including endometriosis and uterine fibroids. Much of her research to date has focused on understanding the role of the potentially modifiable risk factors of diet and lifestyle on the risk of these conditions. A more recent facet of Dr. Harris' research is to explore the interrelatedness of these conditions and their shared risk factors. As ovarian cancer is rare, she is particularly interested in identifying women, such as those with endometriosis or polycystic ovary syndrome (PCOS), who may be at higher risk because these women may benefit from screening modalities for ovarian cancer which are currently not appropriate for population-based use. Identification of women at high risk for ovarian cancer and breast cancer is also important as it allows for targeted prevention strategies and can guide clinical decisions regarding frequency of screening and chemoprevention strategies for both of these cancers. Finally, understanding the influence of genetic factors, both alone or as a part of gene-environment interactions may facilitate prevention and help identify women most at risk for ovarian and breast cancer.
Sharon Kwan , MD
Email: shakwan@uw.edu
Phone: (206) 543-5972
Dr. Kwan is an interventional radiologist. She performs minimally invasive procedures using image-guidance, with a clinical focus in the treatment of liver cancer and uterine fibroids. Dr. Kwan's research interests include healthcare utilization, comparative effectiveness, hepatocellular carcinoma, transarterial chemoembolization; Y-90 radioembolization and transjugular intrahepatic portosystemic shunts.
Wayne Monsky , MD, PhD
Email: wmonsky@uw.edu
Phone: 206 598-1454
Dr. Monsky is director of interventional radiology at the Harborview Medical Center and also provides clinical care at the UW Medical Center. He is a UW associate professor of radiology. He is an expert in all aspects of interventional radiology including minimally invasive therapies for cancer, uterine fibroids, deep venous thrombosis, and gastrointestinal bleeding. He also conducts research on novel approaches to treat solid malignancies, remove blood clots and the use of advanced ultrasound techniques to diagnose and treat a number of diseases, as a member of the Ultrasound-based Washington Molecular Imaging and Therapy Center. He has been integral to the development and optimization of a number of state-of-the-art novel medical devices.